MedScience Ventures

Profile

MedScience Ventures (MSV) is a U.S., Europe, and Asia-based fund management company focused on emerging life science and medical technologies. It was founded by Stefano Ciampolini, Sherwyn Hung, and Christopher Ford, all with extensive experience in the healthcare and medical technology sectors. The firm partners with innovative, emerging companies to provide consulting services, obtain exclusive license rights in specific markets, and evaluate potential equity investments. The team includes managing partners with backgrounds in healthcare and finance, leveraging their expertise to drive investments in the life sciences sector.

MSV invests in sectors including Life Sciences, Medical Devices, HealthTech, and Pharmaceuticals. The firm operates across North America, Europe, and Asia, providing financial backing and strategic support to portfolio companies. Although fund sizes and specific investment stages are not detailed, MSV aims to support companies through various growth phases by leveraging industry connections and expertise. The firm has not disclosed total AUM or specific fund names.

Notable investments by MedScience Ventures include companies like Pure Life Renal, a U.S. dialysis services company, and Sleepiz, a Swiss respiratory medical devices company. Other investments include UV Light Care, Yofumo Technologies, and Pathfinder Medical, focusing on areas from biomass decontamination to medical device innovation. Through strategic partnerships and an experienced team, MSV seeks to foster significant advancements in the life sciences sector.